Jaeger™ and Pulmonx Announce Strategic Partnership to Integrate Data Qualification Capabilities into SentrySuite™

MORENO VALLEY, Calif., Aug. 27, 2025 /PRNewswire/ – Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmonx Corporation, Redwood City, California, USA, to integrate advanced data qualification functionality into SentrySuite™, the Jaeger™ Medical industry-leading software platform for respiratory diagnostics.

The partnership enables direct incorporation of intelligent data validation and qualification logic into SentrySuite™, enhancing the platform’s ability to support consistent and high-quality clinical decision-making. This integration empowers healthcare providers to more easily identify patients with secondary findings, such as severe hyperinflation secondary to emphysema, that may qualify them for innovative new treatments such as the Zephyr Valve. It also enables them to integrate those findings seamlessly into their diagnostic workflow.

“We are excited to partner with Pulmonx to bring this next-generation data intelligence into the SentrySuite™ platform,” said Chris Tue, Executive Vice President, Marketing and R&D at Jaeger™ Medical. “Our shared commitment to technological innovation and clinical excellence made this collaboration a natural fit. By integrating qualification capabilities into SentrySuite™, we are streamlining how clinicians interpret and act on respiratory data.”

About Jaeger™ Medical
Jaeger™ Medical, a Trudell Medical Group company, is a global leader in respiratory diagnostics, delivering cutting-edge technology to healthcare professionals worldwide. With a legacy spanning over 70 years, Jaeger™ Medical has been at the forefront of pulmonary function testing, shaping the future of respiratory health through innovation in diagnosis and clinical decision making.

For more information about the Jaeger™ Medical products, please visit: www.jaegerrdx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/jaeger-and-pulmonx-announce-strategic-partnership-to-integrate-data-qualification-capabilities-into-sentrysuite-302537873.html

SOURCE Jaeger Medical

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

15 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

15 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

15 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

15 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

15 hours ago